NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that it is in advanced discussions with Poplar Healthcare to establish a strategic partnership that includes, among other transactions, the acquisition of the customer base of Poplar’s Hematopathology division, OncoMetrix . The planned transaction contemplates that Precipio will assume responsibility for OncoMetrix’s customer base and associated reve
February 18, 2020
· 4 min read